GSK Snaps Up US Biotech Rapt Therapeutics for $2.2bn
GSK just made its first big move under new boss Luke Miels—and it’s a chunky one….
-
-
Hikma Pharmaceuticals CEO Replaced After Share Price Drops 25%
FTSE 100 Drug Maker Brings Back Former Chief as Shares Tumble When your share price tanks…
